The high heterogeneity of psychiatric disorders leads to a lack of diagnostic precision.
Therefore, the search of biomarkers is a fundamental aspect in psychiatry to reach a more …

We conducted a review of systematic reviews (SRs) and randomized-controlled trials (RCTs)
to analyze efficacy and safety of cannabis-based medication in patients with mental …

Cannabis-derived compounds, such as cannabidiol (CBD) and delta-9-trans-
tetrahydrocannabinol (THC), are increasingly prescribed for a range of clinical indications …

Background and Objectives Cannabis use is common in people with and mood and anxiety
disorders (ADs), and rates of problematic use are higher than in the general population …

Background and aim Cannabis sativa L. is a medicinal plant with a long history. Phyto-
cannabinoids are a class of compounds from C. sativa L. with varieties of structures …

Cannabinoid receptors type 1 (CB1) and 2 (CB2) are widely expressed in the human body,
and are attractive drug targets in the prevention and management of central nervous system …

Schizophrenia is a severe neuropsychiatric disease that is associated with neurobiological
alterations in multiple brain regions and peripheral organs. Negative symptoms and …

Cannabis use disorder is frequent in schizophrenia patients, and it is associated with an
earlier age of onset and poor schizophrenia prognosis. Serotonin 2A receptors (5‐HT2AR) …

Background The investigation of lncRNAs has provided a novel perspective for elucidating
mechanisms underlying diverse physiological and pathological processes. Compelling …

Gene variation linked to physiological functions is recognised to affect elite athletic
performance by modulating training and competition-enabling behaviour. The fatty acid …